 | Up a level |
2022
Muinos-Buehl, A., Rombo, R., Janzen, E., Ling, K. K., Hupperich, K., Rigo, F., Bennett, C. F. and Wirth, B. (2022). Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarks. Neurobiol. Dis., 171. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE. ISSN 1095-953X
Schorling, D., Koelbel, H., Hentschel, A., Pechmann, A., Meyer, N., Wirth, B., Rombo, R., Sickmann, A., Kirschner, J., Schara-Schmidt, U., Lochmueller, H. and Roos, A. (2022). Cathepsin D as biomarker in CSF of nusinersen-treated patients with spinal muscular atrophy. Neuromusc. Disord., 32. S. S64 - 1. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1873-2364